BACKGROUND: Many individuals with diabetes mellitus, hypertension, and hyperlipidemia have difficulty achieving control of all 3 conditions. We assessed the incidence and duration of simultaneous control of hyperglycemia, blood pressure, and low-density lipoprotein cholesterol in patients from 2 health care systems in Colorado. METHODS AND RESULTS: We performed a retrospective cohort study of adults at Denver Health and Kaiser Permanente Colorado with diabetes mellitus, hypertension, and hyperlipidemia from 2000 through 2008. Over a median of 4.0 and 4.4 years, 16% and 30% of individuals at Denver Health and Kaiser Permanente achieved the primary outcome (simultaneous control with a glycosylated hemoglobin (HbA(1c)) <7.0%, blood pressure <130/80 mm Hg, and low-density lipoprotein cholesterol <100 mg/dL), respectively. With less strict goals (HbA(1c) <8.0%, blood pressure <140/90 mm Hg, and low-density lipoprotein cholesterol <130 mg/dL), 44% and 70% of individuals at Denver Health and Kaiser Permanente achieved simultaneous control. Sociodemographic characteristics (increasing age, white ethnicity), and the presence of cardiovascular disease or other comorbidities were significantly but not strongly predictive of achieving simultaneous control in multivariable models. Simultaneous control was less likely as severity of the underlying conditions increased, and more likely as medication adherence increased. CONCLUSIONS: Simultaneous control of diabetes mellitus, hypertension, and hyperlipidemia was uncommon and generally transient. Less stringent goals had a relatively large effect on the proportion achieving simultaneous control. Individuals who simultaneously achieve multiple treatment goals may provide insight into self-care strategies for individuals with comorbid health conditions.
BACKGROUND: Many individuals with diabetes mellitus, hypertension, and hyperlipidemia have difficulty achieving control of all 3 conditions. We assessed the incidence and duration of simultaneous control of hyperglycemia, blood pressure, and low-density lipoprotein cholesterol in patients from 2 health care systems in Colorado. METHODS AND RESULTS: We performed a retrospective cohort study of adults at Denver Health and Kaiser Permanente Colorado with diabetes mellitus, hypertension, and hyperlipidemia from 2000 through 2008. Over a median of 4.0 and 4.4 years, 16% and 30% of individuals at Denver Health and Kaiser Permanente achieved the primary outcome (simultaneous control with a glycosylated hemoglobin (HbA(1c)) <7.0%, blood pressure <130/80 mm Hg, and low-density lipoprotein cholesterol <100 mg/dL), respectively. With less strict goals (HbA(1c) <8.0%, blood pressure <140/90 mm Hg, and low-density lipoprotein cholesterol <130 mg/dL), 44% and 70% of individuals at Denver Health and Kaiser Permanente achieved simultaneous control. Sociodemographic characteristics (increasing age, white ethnicity), and the presence of cardiovascular disease or other comorbidities were significantly but not strongly predictive of achieving simultaneous control in multivariable models. Simultaneous control was less likely as severity of the underlying conditions increased, and more likely as medication adherence increased. CONCLUSIONS: Simultaneous control of diabetes mellitus, hypertension, and hyperlipidemia was uncommon and generally transient. Less stringent goals had a relatively large effect on the proportion achieving simultaneous control. Individuals who simultaneously achieve multiple treatment goals may provide insight into self-care strategies for individuals with comorbid health conditions.
Authors: Jay S Skyler; Richard Bergenstal; Robert O Bonow; John Buse; Prakash Deedwania; Edwin A M Gale; Barbara V Howard; M Sue Kirkman; Mikhail Kosiborod; Peter Reaven; Robert S Sherwin Journal: J Am Coll Cardiol Date: 2009-01-20 Impact factor: 24.094
Authors: John F Steiner; P Michael Ho; Brenda L Beaty; L Miriam Dickinson; Rebecca Hanratty; Chan Zeng; Heather M Tavel; Edward P Havranek; Arthur J Davidson; David J Magid; Raymond O Estacio Journal: Circ Cardiovasc Qual Outcomes Date: 2009-08-11
Authors: Maria C E Rossi; Antonio Nicolucci; Adolfo Arcangeli; Antonino Cimino; Gualtiero De Bigontina; Carlo Giorda; Illidio Meloncelli; Fabio Pellegrini; Umberto Valentini; Giacomo Vespasiani Journal: Diabetes Care Date: 2008-08-11 Impact factor: 19.112
Authors: Donna Shelley; Batel Blechter; Nina Siman; Nan Jiang; Charles Cleland; Gbenga Ogedegbe; Stephen Williams; Winfred Wu; Erin Rogers; Carolyn Berry Journal: Ann Fam Med Date: 2018-04 Impact factor: 5.166
Authors: William B Borden; Jingyan Wang; Philip Jones; Yuanyuan Tang; Johanna Contreras; Stacie L Daugherty; Nihar R Desai; Salim S Virani; Jason H Wasfy; Thomas M Maddox Journal: Circ Cardiovasc Qual Outcomes Date: 2022-03-11
Authors: Lizheng Shi; Xin Ye; Mei Lu; Eric Q Wu; Hari Sharma; Darren Thomason; Mengxi Zhang; Yao Wang; Vivian A Fonseca Journal: Diabetes Ther Date: 2015-07-23 Impact factor: 2.945
Authors: Emily B Schroeder; Kelly R Moore; Spero M Manson; Megan A Baldwin; Glenn K Goodrich; Allen S Malone; Lisa E Pieper; Stanley Xu; Meredith P Fort; Linda Son-Stone; David Johnson; John F Steiner Journal: J Clin Hypertens (Greenwich) Date: 2020-06-09 Impact factor: 3.738